The price of Prolia in Jordan varies depending on factors such as the pharmacy, dosage, and whether insurance is involved. Information on specific pricing is not readily available in the provided text.
What is Prolia?
Prolia is a brand name for denosumab, a medication used to treat osteoporosis in postmenopausal women at high risk of fracture and to treat bone loss in men receiving certain cancer treatments. It is also used to treat giant cell tumor of bone in certain adults and adolescents. Prolia works by decreasing the activity of cells called osteoclasts, which are responsible for breaking down bone [1].
How is Prolia administered?
Prolia is typically administered as a subcutaneous injection every six months by a healthcare professional [1].
What are the potential side effects of Prolia?
Common side effects of Prolia can include pain in the arms or legs, muscle pain, back pain, and elevated cholesterol levels. More serious side effects may include low calcium levels, severe skin reactions, and osteonecrosis of the jaw, which is a condition where bone tissue dies [1].
When does Prolia's patent expire?
Information regarding the specific patent expiry dates for Prolia is not provided in the available text. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity [2].
Are there alternative treatments for osteoporosis?
Yes, there are alternative treatments for osteoporosis, including other medications like bisphosphonates, which are a common class of drugs used to treat bone loss. The choice of treatment depends on individual patient factors and medical history [1].